Commerzbank Ag set a €73.00 ($85.88) target price on Gerresheimer AG (ETR:GXI) in a research note released on Thursday, July 13th. The brokerage currently has a neutral rating on the stock.

GXI has been the topic of a number of other reports. Goldman Sachs Group, Inc. (The) set a €73.00 ($85.88) price target on Gerresheimer AG and gave the stock a neutral rating in a research note on Friday, June 30th. Berenberg Bank set a €85.00 ($100.00) price target on Gerresheimer AG and gave the stock a buy rating in a research note on Wednesday, May 24th. Deutsche Bank AG set a €82.00 ($96.47) price target on Gerresheimer AG and gave the stock a buy rating in a research note on Friday, July 7th. J P Morgan Chase & Co set a €99.80 ($117.41) price target on Gerresheimer AG and gave the stock a buy rating in a research note on Wednesday, May 31st. Finally, DZ Bank AG reissued a neutral rating on shares of Gerresheimer AG in a research note on Friday, June 9th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of €79.80 ($93.88).

Shares of Gerresheimer AG (GXI) traded up 1.01% on Thursday, hitting €69.89. 70 shares of the stock traded hands. The firm’s 50 day moving average is €71.04 and its 200-day moving average is €73.13. Gerresheimer AG has a 12 month low of €64.00 and a 12 month high of €79.47. The company has a market cap of €2.19 billion and a PE ratio of 19.36.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/07/gerresheimer-ag-etrgxi-given-a-73-00-price-target-by-commerzbank-ag-analysts-updated-updated-updated.html.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Stock Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related stocks with our FREE daily email newsletter.